NMTR 9 Meters Biopharma, Inc.

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.

$0.89  -0.03 (-3.63%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/08/2016
Outstanding shares:  255,667,567
Average volume:  1,768,201
Market cap:   $237,285,069
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    654405109
ISIN:        US6544051096
Sedol:      BLB80L0
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.63
PS ratio:   0.00
Return on equity:   -180.07%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy